Independent Non Exe. Director: Rajesh Desai.

Glenmark's marketing portfolio as of December 2024 had 201 generic products authorised for distribution in the US. The company has 51 applications pending at various stages in the approval process.

Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Glenmark Pharmaceuticals Ltd share price was up by 0.13% from the previous closing price of ₹1,376.30. Who are peers of Glenmark Pharmaceuticals Ltd? The peers of Glenmark Pharmaceuticals Ltd ...

Glenmark has named Anurag Mantri as president, effective April 7. V.S. Mani, executive director and global chief financial officer of the company is opting for early retirement and has decided to ...

Glenmark Pharmaceuticals Ltd. said on Monday that it has appointed Anurag Mantri as president with effect from April 7. The announcement came as VS Mani, Glenmark’s executive director and global CFO, ...

Glenmark Pharmaceuticals Ltd on Thursday (March 20) said its arms Pharmaceuticals Inc., USA, has received final approval from the US Food & Drug Administration (USFDA) for its Olopatadine ...

GLENMARK Pharmaceuticals Ltd. (Glenmark), a leading research-led, global pharmaceuticals company, has partnered with Health Futures Foundation Inc. (HFI) and the municipality of Malinao to launch a ...

Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on therapeutic ...

The agency inspected the factory after a ProPublica investigation in December found that the plant, operated by Glenmark Pharmaceuticals, was responsible for an outsized share of recalls for pills ...